U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07377539) titled 'A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants' on Jan. 21.
Brief Summary: This is a Phase 1, double-blind, sponsor-unblinded, randomized, placebo-controlled study designed to characterize the safety, tolerability, and PK of JZP047 in healthy participants following single-ascending doses of study intervention. Additionally, the effect of food on PK following a single dose of JZP047 will be assessed through comparison of PK between the fed and fasted states.
Study Start Date: Feb. 03
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRU...